Prelude Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.06M | Sell |
|
|||||
|
2025
Q1 | $7.34M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Sell |
|
|||||
|
2024
Q3 | $3.09M | Sell |
|
|||||
|
2024
Q2 | $6.02M | Sell |
|
|||||
|
2024
Q1 | $18.5M | Buy |
|
|||||
|
2023
Q4 | $16M | Buy |
|
|||||
|
2023
Q3 | $14.6M | Buy |
|
|||||
|
2023
Q2 | $9.1M | Buy |
|
|||||
|
2023
Q1 | $6.95M | Buy |
|
|||||
|
2022
Q4 | $5.9M | Buy |
|
|||||
|
2022
Q3 | $1.75M | Buy |
|
|||||
|
2022
Q2 | $1.69M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $302K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $79K | Buy |
|
|||||
|
2020
Q1 | $57K | Sell |
|
|||||
|
2019
Q4 | $150K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $242K | Buy |
|
|||||
|
2018
Q3 | $70K | Sell |
|
|||||
|
2018
Q2 | $881K | Buy |
|
|||||
|
2018
Q1 | $596K | Sell |
|
|||||
|
2017
Q4 | $1.72M | Sell |
|
|||||
|
2017
Q3 | $2.3M | Sell |
|
|||||
|
2017
Q2 | $2.47M | Buy |
|
|||||
|
2017
Q1 | $2.12M | Buy |
|
|||||
|
2016
Q4 | $1.31M | Sell |
|
|||||
|
2016
Q3 | $1.78M | Buy |
|
|||||
|
2016
Q2 | $32K | Sell |
|
|||||
|
2016
Q1 | $67K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $71K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $47K | Buy |
|
|||||
|
2014
Q1 | $27K | Sell |
|
|||||
|
2013
Q4 | $28K | Buy |
|
|||||
|
2013
Q3 | $19K | Buy |
|